Ticker Launch
Sign inTry it free

SPAC · Merger completed

Breeze Holdings Acquisition Corp.

Business combination with YD Biopharma Limited

Breeze Holdings Acquisition Corp. is a blank-check company (SPAC) that raised $100M in its initial public offering on Nov 24, 2020, listing on Nasdaq Capital Market. It completed its business combination with YD Biopharma Limited on Aug 28, 2025; the combined company is YD Bio Limited (YDES). Schiff Hardin advised the SPAC and Loeb & Loeb advised the underwriters on the IPO.

YD Biopharma Limited is a clinical-stage biopharmaceutical company focused on cancer prevention diagnostics and exosome-based therapeutics. It is also a supplier of clinical trial drugs and has begun developing and supplying post-market auxiliary products.

Status
Merger completed
IPO date
Nov 24, 2020
IPO size
$100M
IPO exchange
Nasdaq Capital Market
Target
YD Biopharma Limited
Announced
Sep 25, 2024
Closed
Aug 28, 2025
Combined company
YD Bio Limited (YDES)
SPAC counsel (IPO)
Schiff Hardin
Underwriters' counsel (IPO)
Loeb & Loeb

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2025